BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27118687)

  • 1. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).
    Staplin N; Haynes R; Herrington WG; Reith C; Cass A; Fellström B; Jiang L; Kasiske BL; Krane V; Levin A; Walker R; Wanner C; Wheeler DC; Landray MJ; Baigent C; Emberson J;
    Am J Kidney Dis; 2016 Sep; 68(3):371-80. PubMed ID: 27118687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
    Morton RL; Schlackow I; Staplin N; Gray A; Cass A; Haynes R; Emberson J; Herrington W; Landray MJ; Baigent C; Mihaylova B;
    Am J Kidney Dis; 2016 Jan; 67(1):31-9. PubMed ID: 26385817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking, Smoking Cessation, and Progression of Chronic Kidney Disease: Results From KNOW-CKD Study.
    Lee S; Kang S; Joo YS; Lee C; Nam KH; Yun HR; Park JT; Chang TI; Yoo TH; Kim SW; Oh KH; Kim YH; Park SK; Kang SW; Choi KH; Ahn C; Han SH
    Nicotine Tob Res; 2021 Jan; 23(1):92-98. PubMed ID: 32364601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking habit as a risk amplifier in chronic kidney disease patients.
    Provenzano M; Serra R; Michael A; Bolignano D; Coppolino G; Ielapi N; Serraino GF; Mastroroberto P; Locatelli F; De Nicola L; Andreucci M
    Sci Rep; 2021 Jul; 11(1):14778. PubMed ID: 34285279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
    Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M
    Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
    Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
    Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairment and Progression of CKD.
    Kurella Tamura M; Yaffe K; Hsu CY; Yang J; Sozio S; Fischer M; Chen J; Ojo A; DeLuca J; Xie D; Vittinghoff E; Go AS;
    Am J Kidney Dis; 2016 Jul; 68(1):77-83. PubMed ID: 26972681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
    Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS;
    Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
    Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking Cessation and Coronary Artery Calcification in CKD.
    Lee MJ; Park JT; Chang TI; Joo YS; Yoo TH; Park SK; Chung W; Kim YS; Kim SW; Oh KH; Kang SW; Choi KH; Ahn C; Han SH
    Clin J Am Soc Nephrol; 2021 Jun; 16(6):870-879. PubMed ID: 33879501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
    Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
    Haynes R; Staplin N; Emberson J; Herrington WG; Tomson C; Agodoa L; Tesar V; Levin A; Lewis D; Reith C; Baigent C; Landray MJ;
    Am J Kidney Dis; 2014 Jul; 64(1):40-8. PubMed ID: 24613056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hannan M; Chen J; Hsu J; Zhang X; Saunders MR; Brown J; McAdams-DeMarco M; Mohanty MJ; Vyas R; Hajjiri Z; Carmona-Powell E; Meza N; Porter AC; Ricardo AC; Lash JP;
    Am J Kidney Dis; 2024 Feb; 83(2):208-215. PubMed ID: 37741609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease.
    Nakamura K; Nakagawa H; Murakami Y; Kitamura A; Kiyama M; Sakata K; Tsuji I; Miura K; Ueshima H; Okamura T;
    Kidney Int; 2015 Nov; 88(5):1144-52. PubMed ID: 26200944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.